Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trimethoprim-Sulfamethoxazole or Levofloxacin? A Retrospective Cohort Study of Targeted Therapy for Stenotrophomonas Maltophilia Blood Stream and Lower Respiratory Tract Infections

NCT04639817 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT04639817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04639817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trimethoprim-Sulfamethoxazole or Levofloxacin? A Retrospective Cohort Study of Targeted Therapy for Stenotrophomonas Maltophilia Blood Stream and Lower Respiratory Tract Infections
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Observational
Overall status
Completed
Start date
August 14, 2020
Completion date
April 27, 2021
Enrollment
1,621 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stenotrophomonas infection